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Abstract 
It is now widely recognised that changes of the intracellular calcium concentration have 
deep impact on the differentiation of various non-excitable cells including the elements of the 
vertebrate skeleton. It has become evident that purinergic signalling is one of the most ancient 
cellular mechanisms that can cause such alterations in the intracellular Ca2+-homeostasis, 
which are precisely set either spatially or temporally. Purinergic signalling is believed to 
regulate intracellular Ca2+-concentration of developing cartilage and skeletal muscle cells and 
suggested to play roles in the modulation of various cellular functions. This idea is supported 
by the fact that pluripotent mesenchymal cells, chondroprogenitors or muscle precursors, as 
well as mature chondrocytes all are capable of releasing ectonucleotides, and express various 
types of purinoreceptors and ectonucleotidases. The presence of the basic components of 
purinergic signalling proves that cells of the chondrogenic lineage can utilise this mechanism 
for modulating their intracellular Ca2+ concentration independently from the surrounding 
skeletal muscle and bone tissues, which are well known to release ectopurines during 
development and mechanical stress. In this review, we summarize accumulating experimental 
evidence supporting the importance of purinergic signalling in the regulation of 
chondrogenesis and during skeletal muscle formation. 
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Abbreviations 
AC, adenylate cyclase; ATSC, adipose tissue-derived stem cell; CPC, chondrogenic progenitor 
cell; DFC, dental follicle cell; ECM, extracellular matrix; ERK, extracellular signal-regulated 
protein kinase; FGF, fibroblast growth factor; GPCR, G-protein coupled receptor; HDC, high 
density cultures; IP3, inositol 1,4,5-trisphosphate; MRF, myogenic regulatory factor; MSC, 
mesenchymal stem cell; MSK, musculoskeletal; NFAT, nuclear factor of activated T 
lymphocytes; NMDA, N-methyl-D-aspartate type ionotropic glutamate receptor; PI3-K, 
phosphoinositide 3-kinase; PLC, phospholipase C; PP2B, protein phosphatase 2B 
(calcineurin); RyR, ryanodine receptor; SERCA, sarcoplasmic/endoplasmic Ca2+-ATPase; 
Shh, sonic hedgehog; SOCE, store operated calcium entry; TGF, transforming growth factor; 
TRP, transient receptor potential channel 
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1.   Brief overview of purinergic signalling 
Although the physiological role of extracellular purine nucleotides has been implicated 
early in the 20th century by Szent-Györgyi and his co-worker [1], it was not until the seminal 
work of Burnstock and colleagues on non-adrenergic non-cholinergic transmission in the 
taenia coli [2] that they gained proper acceptance into the growing community of signalling 
molecules. Since then purinergic signalling (coined by Burnstock [3]; see also [4]) has been 
widely accepted in nearly all eukaryotic organisms [5]. 
 
1.1.  P1 receptors 
The evolution of our understanding of purinergic signalling has first led to the 
separation of the then so-called P1 and P2 receptors based on their sensitivity to adenosine (P1 
receptors) and ATP (P2 receptors) [6]. The former are now referred to as adenosine receptors, 
with four members of the family (A1, A2A, A2B, and A3) [7, 8] identified and characterised. All 
adenosine receptors belong to the large superfamily of G-protein coupled receptors (GPCRs) 
and affect the intracellular production of cyclic AMP (cAMP) or inositol 1,4,5-trisphosphate 
(IP3). Whilst A1 and A3 receptors are linked in most cells to Gi proteins and thus lower cAMP 
concentration, both A2 receptors couple to Gs proteins to increase intracellular cAMP levels [9, 
10]. 
 
1.2.  P2 receptors 
Identification of the members of the P2 receptor family started with the description of 
their distinct and sometimes contradictory cellular effects [11]. The original notion in 1985 that 
P2X and P2Y receptors should be distinguished was based on pharmacological data [12]. 
Today seven members of the ionotropic (P2X1–7) and eight members of the metabotropic 
(P2Y1,2,4,6,11–14) purinergic receptors have been cloned and identified in mammals [13, 14]. In 
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case of P2X receptors the seven members of the subfamily refer to seven distinct subunits as 
discussed below. It should be noted that the missing numbers in the P2Y receptor family are 
for members either present in non-mammalian species (such as P2Y3, which was found in 
birds) [15] or have since been recognized as receptors for other signalling molecules (such as 
the lysophosphatidylserine receptors P2Y5 or P2Y10) [16, 17]. The key components of P1 and 
P2 receptor-mediated signalling are illustrated in Fig. 1. 
 
Figure 1. Schematic diagram depicting the molecular components of P1 and P2 receptor-mediated signalling in 
an idealised cell. The downstream effects of P1 adenosine and P2Y purinergic receptor subtypes is determined 
by the G protein; Gq/11 activates the PLC – IP3R pathway, Gs activates AC and thus elevates cAMP levels, and 
Gi inhibits AC activity thus resulting in decreased cAMP levels. Please note that in reality, no cells express all 
types of P1 and P2 receptors that couple to all intracellular signalling pathways shown at the same time. AC, 
adenylate cyclase; PLC, phospholipase C. 
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1.2.1. P2X receptors 
P2X receptors form multimeric, both homo- and heteromeric ligand gated channels 
composed of different members of the subfamily. Typical homomeric channels are the P2X1 
and P2X7 receptors, while a typical heteromeric receptor is the one composed of P2X2 and 
P2X3 subunits (the P2X2/3 receptor [18]). Recent data suggest that functional P2X receptors 
can occur as trimers [19, 20]. Nonetheless, all seven P2X receptor subunits share a similar 
topology, with two transmembrane domains, an extracellular loop, and the amino and carboxy 
terminals located intracellularly. 
The ion channels formed by P2X receptors are cation selective. Their activation, 
therefore, results in the depolarization of the cell membrane. In certain cases the depolarization 
itself, in others the concomitant influx of calcium ions—and the consequent increase in 
intracellular Ca2+ concentration ([Ca2+]i)—is the cellular signal. Ca2+ ions enter either through 
the activated P2X receptor or the depolarization of the cell membrane results in the opening of 
voltage-gated calcium channels. In this respect P2X receptors can either be non-selective 
channels (such as the P2X3 receptor), or exhibit a higher permeability for Ca2+ than for Na+ (as 
the P2X4 receptor where PCa / PNa > 4 for the homomeric channel) [21]. The different P2X 
receptors not only differ in their pharmacology and ion permeation, but also in their gating 
properties (for excellent recent reviews see [22, 23]). 
 
1.2.2. P2Y receptors 
P2Y receptors, like adenosine receptors, couple to G-proteins that influence the activity 
of either phospholipase C (PLC) or adenylate cyclase (AC) thus influencing the intracellular 
production of IP3 or cAMP, respectively. It is important to note that a given P2Y receptor can 
couple to different G-proteins in different cell types; therefore, it is always necessary to assess 
the signalling pathways in the cell under investigation. Nevertheless, P2Y1,2,4,6,11,14 receptors 
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usually activate the IP3 pathway, while P2Y12,13 receptors inhibit AC and thus the production 
of cAMP (for further details see [13]). It should be noted that P2Y receptors can also, as 
described for many GPCRs, couple to ion channels [24]. 
Not only the signalling pathways but also the pharmacology of the P2Y receptors is 
quite unique [25-28]. Whilst most P2Y receptors can be activated by ATP (the exception being 
the P2Y14 receptor which is activated by UDP-glucose or UDP-galactose); for many ATP is 
not the primary agonist. P2Y2,4,6 receptors are considered as pyrimidine receptors as they are 
more (or at least as in case of P2Y2) sensitive to UTP or UDP than to ATP. On the other hand, 
P2Y1,12 receptors are sometimes referred to as ADP receptors as ADP is a better agonist 
(especially for P2Y12) than ATP. 
 
1.2.3. Expression profile of P2 receptors 
The coupling of the P2 receptors to different intracellular signalling pathways in 
different cell types is already interesting, but the most intriguing feature of these receptors is 
their expression pattern. Essentially all cells studied so far seem to express a number of 
different P2 receptors on their surface membrane resulting in a specific expression pattern 
characteristic to the given cell [29, 30]. In certain cases, P2X and P2Y receptors can co-exist 
and modify the effect of one another. This modification can appear as a synergistic effect on 
[Ca2+]i (for reviews on certain cell types see [31, 32]), or through the intracellular regulation 
of the receptor [33]. This expression pattern of P2 receptors changes during differentiation, and 
the pattern seems to be specific for the stage of differentiation. In skeletal muscle, for example, 
as we described it in a series of papers [34-36], purinergic signalling is present on embryonic 
and cultured cells, while it is absent on adult muscle fibres. Furthermore, during differentiation 
in culture, myoblasts responded with small, smaller myotubes with large, while large, 
multinucleated myotubes again with low level changes in [Ca2+]i to purinergic stimulation, 
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reflecting on the probability of a differentiation state-dependent expression pattern of 
purinoreceptors [37]. 
 
2. Purinergic signalling in skeletal muscle differentiation 
Multi-nucleated mature skeletal muscle fibres generally form through the fusion of 
myoblasts developed from mesodermal progenitors. During embryogenesis, myoblasts can 
either proliferate, or differentiate into myotubes. Muscle satellite cells located between the 
basal lamina and the sarcolemma of muscle fibres represent a committed stem cell population 
that is responsible for the postnatal growth and regeneration of skeletal muscle. Satellite cells 
possess multi-lineage differentiation potential, and are thus capable of differentiating into 
osteocytes, adipocytes or myocytes [38, 39]. Skeletal myogenesis depends on the strict 
regulation of specific gene subsets that control the differentiation of the myogenic progenitors 
into myofibres. The transcription factors Pax3 and Pax7 play essential roles in the early 
specification, migration, and myogenic differentiation of satellite cells. Myogenic progenitors 
expressing Pax3 and Pax7 exhibit increased levels of the myogenic regulatory factors (MRFs) 
consisting of a group of transcription factors (MyoD, Myf5, myogenin, MRF4) that regulate 
the skeletal muscle developmental programme. MRF proteins contain a conserved DNA-
binding domain that binds the E box sequence CANNTG. Myf5 and MyoD are expressed in 
proliferating myoblasts and are subject to cell cycle-dependent regulation. Differentiation is 
then induced upon the activation of myogenin together with MEF2 [40].  
Changes in [Ca2+]i exert a profound influence on muscle differentiation. The Ca2+-
calmodulin-dependent Ser/Thr phosphoprotein phosphatase calcineurin (protein phosphatase 
2B or PP2B) is one of the molecular targets of cytosolic calcium in the regulation of skeletal 
muscle differentiation [41]. When activated by Ca2+ and calmodulin binding, calcineurin 
affects gene expression by dephosphorylating specific substrates, including the four 
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calcineurin-dependent members of the nuclear factor of activated T lymphocytes (NFAT) gene 
family, NFATc1, NFATc2, NFATc3, and NFATc4. Following dephosphorylation, NFAT 
translocates from the cytoplasm to the nucleus and activates target genes [42]. Overexpression 
of the canonical TRPC receptor type 1 (TRPC1) in C2C12 myotubes resulted in altered store 
operated calcium entry (SOCE), and attenuated differentiation, accompanied by a lower level 
of nuclear expression of NFAT1 [43]. The neonatal sarcoplasmic/endoplasmic Ca2+-ATPase 
1b (SERCA1b) is the major Ca2+ pump in myotubes and young muscle fibres. Interference with 
SERCA1b mRNA expression results in decreased skeletal muscle differentiation via the 
regulation of [Ca2+]i [44].  
 
2.1. P1 adenosine receptor expression and function during skeletal muscle differentiation 
Differentiation of skeletal muscle fibres both in vivo and in vitro is accompanied by the 
development of voltage-dependent processes and alterations in purinergic signalling. Although 
the role of adenosine in the regulation of blood supply to skeletal muscle is widely discussed, 
relatively little is known about the role of P1 adenosine receptors in the function of mature 
skeletal muscle and in myogenesis. The major source of adenosine formation in skeletal muscle 
is AMP 5’-nucleotidase, which dephosphorylates AMP. In the muscle interstitium, adenosine 
has been reported to appear as the result of nucleotide degradation within the skeletal muscle 
fibres and released to the extracellular space in response to contractions [45]. Adenosine 
receptor transcripts have been identified in skeletal muscle homogenates decades ago; a high 
expression level of A2A receptor mRNA, moderate signals for A2B, and no signals for A1 and 
A3 receptors have been reported [46]. Later, A2A and A2B receptors were demonstrated in the 
sarcolemma and cytosol of human skeletal muscle fibres [47]. Skeletal muscle injury elicited 
a dramatic increase in the expression of A2B and A3, but not A1 and A2A adenosine receptors 
[48]. Moreover, a recent publication suggests a role of A2B receptor-mediated modulation of 
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the properties of acetylcholine receptors on developing mouse myotubes, resulting in sustained 
intracellular Ca2+ spikes [49]. Based on these important findings, P1 adenosine receptors may 
become potential targets for stimulation of skeletal muscle tissue regeneration and functional 
restoration after injury.  
 
2.2. P2 receptor expression and function during skeletal muscle differentiation  
The P2 receptor-mediated signal transduction pathway is present on both cultured and 
freshly isolated embryonic skeletal muscle progenitor cells from mammalian species. P2X4, 
P2X5, P2X7, P2Y1 and P2Y4 receptors have also been demonstrated on multinucleated mouse 
myoblasts, in addition to P2X6 receptors that have been described in developing rat skeletal 
muscle [50]. Metabotropic P2Y receptors could also be detected on developing C2C12 mouse 
myotubes and on embryonic skeletal muscle; furthermore, P2Y1, P2Y2 and P2Y4 receptors 
were also shown to be only temporarily expressed in the embryonic developmental stage and 
down-regulated in postnatal life [36]. Extracellular ATP can regulate myoblast proliferation 
and the differentiation of mammalian skeletal muscle [51, 52]. During differentiation of C2C12 
myoblasts, a continuous increase in their responsiveness to extracellularly applied ATP, as 
measured by the subsequent change in [Ca2+]i, could be detected [37]. When ATP-evoked 
changes in [Ca2+]i were investigated, application of extracellular ATP induced a calcium flux 
that displayed an early peak and then declined to a steady level. The transient component of 
calcium flux depended on the activation of P2X receptors and consequent depolarisation, 
whereas P2Y receptors were found to be responsible for most of the maintained calcium flux. 
Moreover, the time course of the ATP-evoked flux changed with differentiation [53]. P2Y1 and 
P2Y2 receptors have been identified in human skeletal muscle and ATP evoked an increase in 
[Ca2+]i in human myotubes [35, 54]. GTP has also been shown to play a role in the early phases 
of skeletal muscle differentiation [55]. Whilst purinergic receptors clearly play significant roles 
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during the development of skeletal muscle, differentiated muscle fibres barely express them; 
nonetheless, they reappear after denervation [50]. 
PKCα overexpression changed the purinergic receptor expression pattern of immature 
myoblasts and resulted in higher amplitude increases in [Ca2+]i elicited by ATP, but failed to 
do so after depolarising stimuli [37]. Whilst nucleotides activate skeletal muscle ryanodine 
receptors (RyR1), adenosine inhibits the ATP-evoked activation of these receptors. Although 
ATP reversibly activated RyRs, AMP and adenosine were much weaker agonists [56]. Ca2+ 
influx into C2C12 cells via P2X receptors contributes to the phosphorylation of extracellular 
signal-regulated protein kinase 1/2 (ERK1/2); ATP, ADP, 2MeSADP, UTP and UDP induced 
a transient increase in the level of p42 and p44 phosphorylation [50, 57]. This process was fully 
Ca2+ dependent. On the other hand, ATP activated inositol phosphate formation via a P2Y1 
receptor-dependent manner in primary human skeletal muscle cells. In addition, ATP elicited 
ERK1/2 phosphorylation in a time and concentration dependent manner, also mainly via P2Y1 
receptors. The ATP mediated ERK1/2 phosphorylation was strictly dependent on PLC and 
phosphoinositide 3-kinase (PI3-K) activity [58]. The involvement of purinergic receptors in 
skeletal myogenesis is summarised in Fig. 2. 
 
3. Ion channels and Ca2+ signalling of developing chondrocytes 
3.1. Major characteristics of embryonic cartilage formation 
Hyaline cartilage plays a very important role during the formation of vertebrate 
skeletal system as it provides the primitive skeleton of embryos and serves for templates of 
endochondral bone formation. Cartilage develops from mesenchymal tissue in the process 
called chondrogenesis, which is characterised and governed by the expression and activity of 
the master transcription factor Sox9 [59]. Pluripotent mesenchymal cells proliferate and 
migrate intensely to form precartilage condensations of chondrogenic cells, in which 
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intercellular junctions and local paracrine signalling pathways drive chondroprogenitors 
towards their final commitment (for reviews see [60, 61]). Initially elongated, the 
chondroprogenitor cells undergo characteristic morphological changes when they turn into 
matrix-producing young chondrocytes, obtaining the biomechanically optimal round shape 
(Fig. 3). Transformation of the macromolecular composition of the extracellular matrix (ECM) 
and adhesion of the cells to the altered microenvironment have fundamental influence on 
chondrogenesis [62]. Ultimately, terminal differentiation resulting in hypertrophic 
chondrocytes, calcification of cartilage ECM, and invasion of blood vessels precedes bone 
formation. In every step of cartilage formation, many players of the signalling pathways are 
influenced by local or generalised changes of intracellular Ca2+ concentration [63].  
 
 
Figure 2. Mammalian skeletal myogenesis. Myogenic precursor cells (also known as satellite cells in adults) 
start to proliferate and differentiate into myoblasts. These mononuclear cells proliferate and fuse together 
(primary fusion step) to give rise to multinucleated myotubes. Additional myoblasts fuse to the existing 
myotubes in the secondary fusion step to produce even larger myotubes which eventually align to form muscle 
fibres. This process is mediated by P2X and P2Y receptors. Where data are available, upwards arrows indicate 
increased activity of downstream pathways following receptor activation. For further details, please see text. 
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Figure 3. The main steps of chondrogenesis. Undifferentiated mesenchymal stem cells (MSCs) are recruited to 
the sites of cartilage formation. Following migration and local proliferation cell density increases 
(condensation), which triggers a set of intracellular events culminating in overt chondrogenesis accompanied by 
a change in morphology (acquire the characteristic ovoid shape) and start to deposit cartilage ECM molecules. 
Amongst other factors, the process is regulated by the master chondrogenic transcription factor Sox9, which is 
responsible for the expression of ECM components. The precisely set Ca2+ homeostasis and the tight regulation 
of other ionic currents through components of the channelome of differentiating and mature chondrocytes are 
essential in mediating the effects of external cues of the chondrocyte niche such as the mechanical or osmotic 
environment. Various protein kinases/phosphoprotein phosphatases also play essential roles in the control of 
chondrogenesis. The involvement of P1 adenosine receptors, as well as P2X and P2Y purinergic receptors in 
modulating the main steps of chondrogenesis is shown in boxes below the schematic diagrams. Where data are 
available, arrows indicate increased (upwards arrow) or decreased (downwards arrow) activity of downstream 
pathways following receptor activation. See further explanation in text. 
Matta–Fodor–Csernoch–Zakany: Purinergic signalling in chondrogenesis and skeletal muscle formation 
Please cite this article in press as follows: C. Matta, et al., Purinergic signalling-evoked intracellular Ca2+ concentration changes in the regulation of 
chondrogenesis and skeletal muscle formation, Cell Calcium (2016), http://dx.doi.org/10.1016/j.ceca.2016.01.006 
15 
 
Permanent hyaline cartilage remains present at certain locations of the skeleton, such 
as the nasal septum, the wall of airways and the surfaces of bones in synovial joints. Articular 
cartilage differs from other permanent cartilages by the lack of perichondrium on its surface. 
This feature is an important factor in the very low regeneration capability of this tissue. Hyaline 
cartilage is unique among connective tissues in several aspects: it is colonized by a single cell 
type, the chondrocyte; it does not contain nerves; and healthy cartilage is not penetrated by 
blood or lymphatic vessels [64]. Mature chondrocytes divide rarely if at all and live in a unique 
niche in a specialised ECM, which is the product of these cells. A typical location of this tissue 
in the skeletal system is the surface of bones in synovial joints, where complex load, 
deformation, and fluid shear are exerted on articular cartilage during locomotion and other 
physical activities. Chondrocytes are also challenged by osmotic and hypoxic stress under 
physiological circumstances [65]. Whilst optimal mechanical stimulation is necessary for 
cartilage development [66] and homeostasis, extreme levels of loading have also been shown 
to initiate cartilage degradation [65]. A recent publication reported that in ovo immobilization 
of chicken embryos resulted in fused articular surfaces in the knee joint [67]. Albeit 
chondrocytes are generally considered as non-excitable cells the above findings all suggest that 
either mature or differentiating chondrocytes are able to “sense” various environmental stimuli 
and transmit those into the cells, where signal transduction pathways influencing metabolism, 
transcriptional activity, differentiation programmes or proliferation of cartilage cells can be 
altered.	  
 
3.2. Ion channels and intracellular Ca2+-concentration changes in chondrogenic cells 
Plasma membrane ion channels are the primary candidates to link these extracellular 
stimuli to the internal milieu of either developing or mature chondrocytes. Indeed, various 
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plasma membrane receptors which are sensitive to mechanical load, fluid sheer or osmotic 
changes, are present and function on mature chondrocytes (for a review, see [68]). Some of 
them, such as several members of the Transient Receptor Potential (TRP) channel family [69], 
purinoreceptors [70], or the N-methyl-D-aspartate type ionotropic glutamate receptor 
(NMDAR) [71] are known to function as cation channels with considerable permeability for 
Ca2+ and are involved in the Ca2+ homeostasis of pluripotent mesenchymal stem cells (MSCs) 
(for a recent review, see [63]). 	  
Cartilage formation requires a concerted action of numerous intracellular signal 
transduction molecules [60], many of which are sensitive to the changes of intracellular Ca2+ 
concentration. Our previous findings indicated that inhibition of calcineurin by cyclosporine A 
seriously impaired in vitro chondrogenesis in chicken limb-bud derived high density cultures 
(HDC) [72]. We also detected precisely set changes in basal cytosolic Ca2+ concentration 
during chondrogenesis when a day-by-day variation of this cellular parameter was detected by 
single cell fluorescent Ca2+ imaging [73]. A characteristic peak in cytosolic free Ca2+ 
concentration was found on day 3 of culturing (approximately 140 nM, as compared to 100 
nM prior to or after this day). Of note, this is the period of the culturing when the majority of 
the chondrogenic cells differentiate to matrix producing chondroblasts in this model. This peak 
in cytosolic Ca2+ concentration was found to be indispensable to proper differentiation of cells 
in HDC because chelation of extracellular Ca2+ on culturing days 2 or 3 resulted in significantly 
lower cytosolic Ca2+ concentration and impaired chondrogenesis, demonstrated by an almost 
completely abolished cartilage matrix production. In these experiments, proliferation of the 
differentiating chondrogenic cells was extremely dependent on a well-defined range of 
cytosolic Ca2+ concentration [73]. In further experiments, we have proved the dependence of 
the above changes in cytosolic Ca2+ concentration on purinergic signalling via ionotropic P2X4 
receptors [74]. Besides the long term day-by-day changes of the cytosolic Ca2+ concentration, 
Matta–Fodor–Csernoch–Zakany: Purinergic signalling in chondrogenesis and skeletal muscle formation 
Please cite this article in press as follows: C. Matta, et al., Purinergic signalling-evoked intracellular Ca2+ concentration changes in the regulation of 
chondrogenesis and skeletal muscle formation, Cell Calcium (2016), http://dx.doi.org/10.1016/j.ceca.2016.01.006 
17 
we have also detected rapid Ca2+ oscillations in the differentiating chondrocytes. The 
periodicity of these oscillations was approximately 4–5 transients/minute and the oscillations 
in chondrifying mesenchymal cells were found to be mainly dependent on the availability of 
extracellular Ca2+ as removal of free Ca2+ from the bath solution immediately abolished these 
oscillations in most of the cells examined. However, store-operated calcium entry (SOCE) was 
also found to be essential for the maintenance of the Ca2+ oscillations [75]. We demonstrated 
that a developmental switch in the expression and function of voltage-gated potassium channels 
[76] and activity of voltage dependent Ca2+ channels [75, 77] influenced Ca2+ oscillations in 
chondrogenic cells. 	  
The significance of Ca2+ signalling in chondrogenesis can be underlined by the fact that 
Sox9, the master transcription factor of chondrogenesis and key element of sex determination, 
can be translocated to the nucleus either via calmodulin in a Ca2+-dependent fashion or via 
importin-β in a Ca2+-independent mechanism. Impairment of the calmodulin-driven nuclear 
shuttle of Sox9 causes campomelic dysplasia/sex reversal, a severe human syndrome affecting 
skeletogenesis and sexual differentiation [78].	  
Considering the above, the importance of the changes of intracellular Ca2+ 
concentration during differentiation of chondrocytes, as well as in maintenance of the healthy 
mature cartilage seems to be unquestionable. In the following sections of this review article, 
we focus on the current knowledge on the significance of purinergic signalling in the regulation 
of the differentiation and Ca2+ homeostasis of chondrocytes 	  
 
4. Purinergic signalling during chondrogenesis 
Mature articular chondrocytes have been shown to express various P1 and P2 purinergic 
receptors including A1, A2A and A2B, as well as different subtypes of P2X (P2X1,2,3,4,7) and P2Y 
(P2Y1,2,4,6) receptors [79, 80]. Given that P1 and P2 receptors are important regulators of 
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mechanosensation or mechanotransduction in mature chondrocytes [79], it is plausible to 
assume that they may also be involved in the regulation of chondrogenesis. 
The role of purinergic signalling has been widely studied in the differentiation of many 
cell types (for a review, see [81]). Since the development of cartilage (and to a limited extent 
its repair) is dependent on the differentiation of chondroblasts and chondrocytes from 
chondroprogenitor MSCs [82], we will focus on the chondrogenic differentiation of these cells 
in the context of purinergic signalling. Despite the limited number of studies in this field, 
accumulating evidence supports the importance of extracellular nucleotides in the regulation 
of maintenance, proliferation and differentiation of MSCs.  
 
4.1. P1 adenosine receptor expression and function during chondrogenesis 
As it could be expected from a cell type with a broad, multilineage differentiation 
potential, MSCs were found to express A1,2A,2B and A3 receptor subtypes of the P1 adenosine 
receptor family; activation of A1 and A2A receptors has been shown to increase proliferation, 
whilst the most abundant A2B receptors mediate osteogenic differentiation of primary human 
bone marrow stromal cells [83]. In a different study, stimulation of the A1 receptor was 
demonstrated to enhance osteogenic differentiation of human dental pulp-derived MSCs [84]. 
Interestingly, no data are available as to whether P1 adenosine receptors are de facto involved 
in the regulation of chondrogenesis. In a migratory cell population derived from human 
osteoarthritic knee articular cartilage with a strong chondrogenic differentiation potential 
termed CPCs [85], we have recently established the P1 purinergic receptor profile, which 
correlated well with that of MSCs as CPCs expressed A1, A2A, and A2B, but no A3 receptors 
[86]. It should be noted that the same P1 receptor subtypes were found to be expressed in 
articular chondrocytes [87]. A2A and A2B adenosine receptors are of particular importance as 
these are coupled to Gs, which stimulates AC and produces a cAMP signal [88]; cAMP 
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mediated signalling is a well known mediator of chondrogenesis as well as in maintaining the 
chondrocyte phenotype [89]. 
 
4.2. P2 purinergic receptor expression and function during chondrogenesis 
Compared to P1 receptors, more data supporting the role of P2 receptors in 
chondrogenesis is available. However, there are some controversies as to whether purinergic 
signalling is a positive or negative regulator of chondrogenesis; some reports suggest that 
extracellular nucleotides negatively regulate cartilage metabolism whilst others describe 
beneficial effects of ATP.  
The P2 receptor profiling of human MSCs derived from various sources have only 
recently been performed. Adipose tissue-derived stem cells (ATSCs) and dental follicle cells 
(DFCs) derived from the ectomesenchyme expressed some P2X (P2X3,4,5,6,7) and all 8 P2Y 
receptor subtypes; interestingly, no mRNA transcripts of P2X1 and P2X2 receptors were 
identified in either cell type [90, 91]. Extracellular nucleotides acting through P2 receptors 
(primarily P2X6, P2Y4, P2Y6, P2Y13 and P2Y14) are important modulators of MSC 
differentiation towards the osteogenic and adipogenic lineages [90-92]. The purinergic concept 
of MSC differentiation is further supported by a recent study showing substantial changes in 
ecto-nucleotide metabolism and ecto-nucleotidase expression profiles following chondrogenic 
differentiation of human umbilical cord-derived MSCs [93]. 
The specific mechanism as to how P2 receptors mediate these events remains elusive. 
Ca2+ signalling is a major regulator of differentiation [63] and nucleotides acting through P2 
receptors can either elicit Ca2+ influx or mobilise Ca2+ from intracellular stores. The Ca2+ 
homeostasis of MSCs has been mapped earlier and Ca2+ oscillations have been reported to be 
driven by an autocrine/paracrine purinergic loop, whereby ATP released through hemi-gap 
junctions triggered P2Y1 metabotropic purinergic receptors and Ca2+ release via PLC-β and 
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IP3R signalling [94]. In migratory CPCs, we have recently confirmed the mRNA and protein 
level expression of certain P2X (P2X1,4,5,6,7, but not P2X2 and P2X3) and all P2Y receptors 
[86]. Our results suggest the functionality of P2Y1, P2Y2, P2Y4, as well as P2X4 and P2X6 
receptor subtypes in CPCs, which shows a very good correlation with previous data implicating 
the P2 receptor subtypes P2X6, P2Y4 and P2Y14 to be key regulators in MSC commitment [91]. 
Given the multilineage differentiation capacity of CPCs to the osteogenic, adipogenic and 
chondrogenic lineages, their P1 and P2 receptor profiles are in good correlation with the above 
data. Further experiments need to confirm the specific role of these receptors in lineage-specific 
differentiation. 
Whilst signalling through P2 receptors seems to promote differentiation of MSCs, their 
role in chondrogenic micromass cultures is less straightforward. The first study on the 
involvement of purinergic signalling in chondrogenesis in vitro showed that ATP acting on the 
P2Y1 receptor inhibited cartilage formation in HDCs of embryonic chick limb bud-derived 
mesenchymal cells [95]. In contrast, our group has reported that cells in HDC responded to 
extracellular ATP by elevating their intracellular Ca2+ levels mainly at the time of chondroblast 
formation and administration of ATP to the culture medium stimulated chondrogenesis [74]. 
Whilst Western blot analyses revealed the presence of many purinoreceptors, i.e. P2X1,4,5 and 
P2X7 of the P2X-family and P2Y1,2,3,4 and P2Y5 of P2Y receptors in cells of differentiating 
micromass cultures, the receptor primarily responsible for the rise of Ca2+ concentration 
evoked by extracellular ATP seemed to be P2X4 receptor [74]. Earlier we reported that this 
receptor contributed to the elevation of cytosolic Ca2+ levels of chondrogenic cells on day 3 of 
culturing [73]. The apparent discrepancy between these studies may be explained by the fact 
that whilst Meyer and colleagues used cultures established from mesenchymal cells derived 
from the forelimbs only [95], the micromass cultures used in our study were of mixed origin 
containing progenitor cells from both fore and hind limb buds [74]. It has long been known 
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that chondrogenesis in HDC derived from wing and leg precartilage cells is affected differently 
by certain morphogens such as transforming growth factor-β1 (TGF-β1) or retinoic acid, and 
they also differ from each other in condensation morphology and organisation of fibronectin 
during the early phase of differentiation [96]. The discrepancy may also indicate that ATP, 
acting through different purinergic receptor subclasses, is able to precisely, albeit sometimes 
contrarily, regulate chondrogenesis. 
Another study has also shown that intracellular oscillations in ATP, acting via P2X4 
receptors, have an essential role in pre-chondrogenic condensation [97] and mediate the 
inductive action of fibroblast growth factor (FGF) and sonic hedgehog (Shh), proposing the 
hypothesis that morphogens organise skeletal patterns via ATP oscillations [98]. Purinergic 
signalling was reported playing role in foetal articular cartilage repair in rat embryos in vivo. 
Although the authors did not identify the specific receptor involved in the process, they showed 
the presence of a signalling pathway that used the intercellular transfer of ATP and increased 
cytosolic Ca2+ levels, and expression of c-fos in foetal articular cartilage [99]. The involvement 
of P1 and P2 receptors in chondrogenesis are summarised in Fig. 3. 
 
5. Concluding remarks 
It is clear that precisely set intracellular Ca2+-concentration changes exhibited by 
developing chondrocytes and skeletal muscle fibres play essential roles at every step of their 
differentiation. Purinergic signalling is one of the most ancient mediators of cell-to-cell 
communication and can modulate the pattern of the intracellular Ca2+-concentration changes. 
Bone, skeletal muscle and cartilage abundantly express various purinergic receptors and 
accumulating evidence support that extracellular purines participate in the regulation of the 
proliferation, differentiation and mechanosensation of skeletal tissues. Developing 
chondrocytes and skeletal muscle fibres express various types of purinoreceptors, offering the 
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ability of their responsiveness to ectopurines and experiments prove that both tissues contain 
resident cells secreting various purinergic ligands.  
On the basis of these experimental data, one can propose that it would be plausible to 
utilize ectopurines to facilitate tissue regeneration of damaged cartilage or skeletal muscle. 
Nonetheless, the ubiquitous nature of signalling mediated by ectopurines, that is, its presence 
and operation in virtually all tissues and cells, has to be considered if any in vivo therapeutic 
intervention is designed to target this mechanism. 
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